Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Mirabegron in Pediatric Refractory OAB
NCT02476175Phase 3Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Apr 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by CHU de Québec-Université Laval. Started Apr 2013; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02476175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476175.